Schlensker K H, Krüger A A
Universitäts-Frauenklinik Köln.
Geburtshilfe Frauenheilkd. 1996 Sep;56(9):494-500. doi: 10.1055/s-2007-1022294.
The aim of the study is to analyse the benefit of rh-prophylaxis at the Universitäts-Frauenklinik Köln from 1967 to 1990.
During that period 28,761 births, of whom 2602 were non-sensitized rh-negative mothers with a rh-positive child (9.04%), were assessed. 2223 mothers received rh-prophylaxis, in 379 cases rh-prophylaxis was omitted particularly within the first 4 years of the study period, due to a limited provision of anti-D immunoglobulines. From 1972 onwards postnatal rh-prophylaxis was omitted in only 3%. In 14.5% of the 379 women without rh-prophylaxis contamination of the maternal circulation system with HbF cells was confirmed by the Kleihauer-Betke-Test. In 98.4% of the cases rh-prophylaxis was performed postnatally within the first 72 hours.
During the study period the initial dosage of IgG anti-D was set at 55 - 150 microgram i.v. (n = 217) and later increased to 150 - 250 microgram i.v. (n = 1109) and finally to 300 - 330 microgram i.m. (n = 897). After rh-prophylaxis presence of HbF cells in the maternal circulation was found in 5.5% of the mothers of group 1, in 2.1% of the second group and in 1.1% of the third group. In the group of mothers without rh-prophylaxis 69 had a second delivery and rh-sensitsation was found in 7.3% of these cases. Of 537 women having received rh-prophylaxis who delivered a second rh-positive child, 9 (1.7%) showed rh-sensitisation. of the 352 women with rh-incompatibility 8 (2.3%) had already been sentisized during their first pregnancy.
The study confirms that postnatal application of anti-D immunoglobulins is effective to a great extent but does however not completely exclude rh-sensitisation. Furthermore, we recommend the additional prenatal rh-prophylaxis as introduced by the German maternity regulations since 1990.
本研究的目的是分析1967年至1990年期间科隆大学妇产科进行Rh预防的益处。
在此期间,对28761例分娩进行了评估,其中2602例为未致敏的Rh阴性母亲且孩子为Rh阳性(9.04%)。2223例母亲接受了Rh预防,在379例病例中,特别是在研究期的前4年,由于抗D免疫球蛋白供应有限,未进行Rh预防。从1972年起,产后Rh预防仅在3%的病例中被省略。在379例未进行Rh预防的妇女中,14.5%通过Kleihauer-Betke试验证实母体循环系统中有HbF细胞污染。在98.4%的病例中,产后Rh预防在出生后72小时内进行。
在研究期间,IgG抗D的初始剂量设定为静脉注射55 - 150微克(n = 217),后来增加到静脉注射150 - 250微克(n = 1109),最后增加到肌肉注射300 - 330微克(n = 897)。Rh预防后,第一组母亲中有5.5%、第二组中有2.1%、第三组中有1.1%的母亲在母体循环中发现有HbF细胞。在未进行Rh预防的母亲组中,69例再次分娩,其中7.3%的病例出现Rh致敏。在537例接受Rh预防且再次分娩出Rh阳性孩子的妇女中,9例(1.7%)出现Rh致敏。在352例Rh血型不合的妇女中,8例(2.3%)在首次怀孕时就已致敏。
该研究证实产后应用抗D免疫球蛋白在很大程度上是有效的,但并不能完全排除Rh致敏。此外,我们建议按照自1990年起德国孕产妇法规引入的方式,增加产前Rh预防。